Literature DB >> 20926182

Global DNA hypomethylation-induced ΔNp73 transcriptional activation in non-small cell lung cancer.

Alexandros Daskalos1, Stella Logotheti, Soultana Markopoulou, George Xinarianos, John R Gosney, Anastasia N Kastania, Vassilis Zoumpourlis, John K Field, Triantafillos Liloglou.   

Abstract

p73 possesses an extrinsic P1 promoter and an intrinsic P2 promoter controlling the expression of the pro-apoptotic TAp73 isoforms and the anti-apoptotic ΔΝp73 isoforms respectively. In this study, we investigated the DNA methylation status of both promoters as a means of epigenetic transcriptional control of their corresponding isoforms in 102 primary non-small cell lung carcinomas (NSCLCs). We demonstrated that while P1 hypermethylation-associated reduction of TAp73 mRNA levels is relatively infrequent, the P2 hypomethylation-associated over-expression of ΔΝp73 mRNA is a frequent event, particularly among squamous cell carcinomas. P2 hypomethylation strongly correlated with LINE-1 element hypomethylation, indicating that ΔΝp73 over-expression may be a passive consequence of global DNA hypomethylation.
Copyright © 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 20926182     DOI: 10.1016/j.canlet.2010.09.009

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  19 in total

Review 1.  Epigenetics of lung cancer.

Authors:  Scott M Langevin; Robert A Kratzke; Karl T Kelsey
Journal:  Transl Res       Date:  2014-03-12       Impact factor: 7.012

2.  Overexpression and ratio disruption of ΔNp63 and TAp63 isoform equilibrium in endometrial adenocarcinoma: correlation with obesity, menopause, and grade I/II tumors.

Authors:  Eleni Vakonaki; Nikolaos Soulitzis; Stavros Sifakis; Danae Papadogianni; Dimitrios Koutroulakis; Demetrios A Spandidos
Journal:  J Cancer Res Clin Oncol       Date:  2012-03-24       Impact factor: 4.553

3.  Association of p73 G4C14-to-A4T14 polymorphism with lung cancer risk.

Authors:  Hua Liu; Yuli Liang; Hua Liao; Lanying Li; Hongyun Wang
Journal:  Tumour Biol       Date:  2014-06-19

Review 4.  A balancing act: orchestrating amino-truncated and full-length p73 variants as decisive factors in cancer progression.

Authors:  D Engelmann; C Meier; V Alla; B M Pützer
Journal:  Oncogene       Date:  2014-11-10       Impact factor: 9.867

Review 5.  Clinical implications of the LINE-1 methylation levels in patients with gastrointestinal cancer.

Authors:  Yoshifumi Baba; Asuka Murata; Masayuki Watanabe; Hideo Baba
Journal:  Surg Today       Date:  2013-10-23       Impact factor: 2.549

Review 6.  Mechanisms, function and clinical applications of DNp73.

Authors:  Cuixia Di; Lina Yang; Hong Zhang; Xiaofei Ma; Xin Zhang; Chao Sun; Hongyan Li; Shuai Xu; Lizhe An; Xun Li; Zhongtian Bai
Journal:  Cell Cycle       Date:  2013-06-13       Impact factor: 4.534

Review 7.  Alterations of p63 and p73 in human cancers.

Authors:  Kazushi Inoue; Elizabeth A Fry
Journal:  Subcell Biochem       Date:  2014

8.  p53 Family: Role of Protein Isoforms in Human Cancer.

Authors:  Jinxiong Wei; Elena Zaika; Alexander Zaika
Journal:  J Nucleic Acids       Date:  2011-10-09

9.  DNA methylation biomarkers offer improved diagnostic efficiency in lung cancer.

Authors:  Georgios Nikolaidis; Olaide Y Raji; Soultana Markopoulou; John R Gosney; Julie Bryan; Chris Warburton; Martin Walshaw; John Sheard; John K Field; Triantafillos Liloglou
Journal:  Cancer Res       Date:  2012-09-07       Impact factor: 12.701

Review 10.  The significance of epigenetic alterations in lung carcinogenesis.

Authors:  Ewa Brzeziańska; Agata Dutkowska; Adam Antczak
Journal:  Mol Biol Rep       Date:  2012-10-20       Impact factor: 2.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.